Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effect of Epoetin Alfa on Hemoglobin, Symptom Distress, and Quality of Life in Patients Receiving Chemotherapy

This study has been completed.
Sponsor:
Information provided by:
Ortho Biotech Clinical Affairs, L.L.C.
ClinicalTrials.gov Identifier:
NCT00524407
First received: August 30, 2007
Last updated: April 1, 2010
Last verified: April 2010